New stock news | Xuetong submitted a listing application to the Hong Kong Stock Exchange again.
According to the disclosure on May 19th by the Hong Kong Stock Exchange, Xiaoe Inc. (referred to as "Xiao'eTong") submitted its application for listing on the main board of the Hong Kong Stock Exchange.
According to the disclosure by the Hong Kong Stock Exchange on May 19th, Xiaoe Inc. (referred to as Xiaoe) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CICC as its exclusive sponsor. The company had previously submitted a listing application to the Hong Kong Stock Exchange on August 22, 2025. According to the prospectus, Xiaoe is a product-driven SaaS solution provider in the field of private domain operations, empowering enterprises to build, operate, and expand their decentralized e-commerce infrastructure. The company's cloud-based integrated solutions include e-commerce, digital marketing, and CRM modules, seamlessly integrating private domain operations from traffic conversion to customer relationship management, from marketing to transaction facilitation, into a unified system throughout the entire lifecycle.
Related Articles
.png)
HK Stock Market Move | LAOPU GOLD (06181) falls by more than 5% again. Institutions point out that the short-term data of SKP Mall cannot represent the overall performance of same-store sales.
HK Stock Market Move | Scarce Resources (09936) surged over 16% this week, with the stock price up over 50% since the beginning of the week, validating the potential of the tantalum and niobium track in high-end prosperity verification.
Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) subsidiary obtains drug registration certificate for Vitamin B6 injection.
HK Stock Market Move | LAOPU GOLD (06181) falls by more than 5% again. Institutions point out that the short-term data of SKP Mall cannot represent the overall performance of same-store sales.
HK Stock Market Move | Scarce Resources (09936) surged over 16% this week, with the stock price up over 50% since the beginning of the week, validating the potential of the tantalum and niobium track in high-end prosperity verification.
Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) subsidiary obtains drug registration certificate for Vitamin B6 injection.
